p16INK4a Is Selectively Silenced in the Tumoral Progression of Mycosis Fungoides
- 1 February 2002
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 82 (2) , 123-132
- https://doi.org/10.1038/labinvest.3780405
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- p16INK4A and p19ARF act in overlapping pathways in cellular immortalizationNature Cell Biology, 2000
- p15INK4BCpG Island Methylation in Primary Acute Leukemia Is Heterogeneous and Suggests Density as a Critical Factor for Transcriptional SilencingBlood, 1999
- Frequent Methylation Silencing of p15INK4b(MTS2) and p16INK4a (MTS1) in B-Cell and T-Cell LymphomasBlood, 1999
- The INK4a/ARF tumor suppressor: one gene—two products—two pathwaysTrends in Biochemical Sciences, 1998
- Loss of RB and MTS1/CDKN2 (p16) expression in human sarcomasHuman Pathology, 1997
- Progression of Mycosis Fungoides Is Associated with Increasing Cutaneous Expression of Interleukin-10 mRNAJournal of Investigative Dermatology, 1996
- Mycosis fungoides and Sezary syndrome [see comments]Blood, 1996
- Frequency of homozygous deletion at p16/CDKN2 in primary human tumoursNature Genetics, 1995
- Infrequent Expression of Protein p53 in Epidermotropic Variants of Cutaneous T-Cell LymphomaThe Journal of Dermatology, 1995
- Value of PCR Detection of TCR7 Gene Rearrangement in the Diagnosis ( Cutaneous Lymphocytic InfiltratesDiagnostic Molecular Pathology, 1994